1. Home
  2. FSBW vs RLMD Comparison

FSBW vs RLMD Comparison

Compare FSBW & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$42.39

Market Cap

322.8M

Sector

Finance

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.93

Market Cap

319.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
RLMD
Founded
1936
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
322.8M
319.0M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FSBW
RLMD
Price
$42.39
$3.93
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$44.00
$9.50
AVG Volume (30 Days)
9.5K
668.7K
Earning Date
01-23-2026
11-13-2025
Dividend Yield
2.67%
N/A
EPS Growth
N/A
N/A
EPS
4.09
N/A
Revenue
$140,954,000.00
N/A
Revenue This Year
$10.46
N/A
Revenue Next Year
$4.42
N/A
P/E Ratio
$10.27
N/A
Revenue Growth
1.07
N/A
52 Week Low
$34.61
$0.24
52 Week High
$44.22
$5.12

Technical Indicators

Market Signals
Indicator
FSBW
RLMD
Relative Strength Index (RSI) 56.75 45.66
Support Level $40.84 $3.98
Resistance Level $42.26 $4.49
Average True Range (ATR) 0.70 0.34
MACD 0.02 -0.09
Stochastic Oscillator 75.89 25.00

Price Performance

Historical Comparison
FSBW
RLMD

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: